These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10421845)

  • 21. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
    Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
    J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
    Bauer JH; Liu KD; You Y; Lai SY; Goldsmith MA
    J Biol Chem; 1998 Apr; 273(15):9255-60. PubMed ID: 9535918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.
    Oakes SA; Candotti F; Johnston JA; Chen YQ; Ryan JJ; Taylor N; Liu X; Hennighausen L; Notarangelo LD; Paul WE; Blaese RM; O'Shea JJ
    Immunity; 1996 Dec; 5(6):605-15. PubMed ID: 8986719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
    Carlesso N; Frank DA; Griffin JD
    J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.
    Migone TS; Lin JX; Cereseto A; Mulloy JC; O'Shea JJ; Franchini G; Leonard WJ
    Science; 1995 Jul; 269(5220):79-81. PubMed ID: 7604283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
    Beadling C; Ng J; Babbage JW; Cantrell DA
    EMBO J; 1996 Apr; 15(8):1902-13. PubMed ID: 8617237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.
    Zhou YJ; Magnuson KS; Cheng TP; Gadina M; Frucht DM; Galon J; Candotti F; Geahlen RL; Changelian PS; O'Shea JJ
    Mol Cell Biol; 2000 Jun; 20(12):4371-80. PubMed ID: 10825200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling.
    Aman MJ; Migone TS; Sasaki A; Ascherman DP; Zhu Mh; Soldaini E; Imada K; Miyajima A; Yoshimura A; Leonard WJ
    J Biol Chem; 1999 Oct; 274(42):30266-72. PubMed ID: 10514520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical cytoplasmic domains of human interleukin-9 receptor alpha chain in interleukin-9-mediated cell proliferation and signal transduction.
    Zhu YX; Sun HB; Tsang ML; McMahel J; Grigsby S; Yin T; Yang YC
    J Biol Chem; 1997 Aug; 272(34):21334-40. PubMed ID: 9261146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction.
    Kawahara A; Minami Y; Miyazaki T; Ihle JN; Taniguchi T
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8724-8. PubMed ID: 7568005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of IL-2 signaling.
    Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Sugamura K
    Leukemia; 1997 Apr; 11 Suppl 3():416-7. PubMed ID: 9209410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
    Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
    EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha.
    Malabarba MG; Kirken RA; Rui H; Koettnitz K; Kawamura M; O'Shea JJ; Kalthoff FS; Farrar WL
    J Biol Chem; 1995 Apr; 270(16):9630-7. PubMed ID: 7721895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery.
    Witthuhn BA; Williams MD; Kerawalla H; Uckun FM
    Leuk Lymphoma; 1999 Jan; 32(3-4):289-97. PubMed ID: 10037026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases.
    Zhang H; Conrad DM; Butler JJ; Zhao C; Blay J; Hoskin DW
    J Immunol; 2004 Jul; 173(2):932-44. PubMed ID: 15240680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.